本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Eterna Therapeutics Inc.

0.2160
+0.01115.42%
盘后0.2061-0.0099-4.58%17:59 EDT
成交量:21.08万
成交额:4.36万
市值:1,343.07万
市盈率:-0.07
高:0.2200
开:0.2040
低:0.1900
收:0.2049
数据加载中...
2024/03/14

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/16

重要事件披露

Form 8-K - Current report
2024/01/31

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/20

重要事件披露

Form 8-K - Current report
2024/01/19

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/19

SEC问询函

Form CORRESP - Correspondence
2024/01/17

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/12/23

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/12/21

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/12/20

重要事件披露

Form 8-K - Current report
2023/12/15

重要事件披露

Form 8-K - Current report
2023/11/17

重要事件披露

Form 8-K - Current report
2023/11/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/01

重要事件披露

Form 8-K - Current report
2023/10/05

重要事件披露

Form 8-K - Current report
2023/09/27

重要事件披露

Form 8-K/A - Current report: [Amend]
2023/09/08

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/09/08

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/09/01

重要事件披露

Form 8-K - Current report
2023/08/29

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals